Acorah Software Products - Accounts Production 16.5.460 false true 31 August 2023 1 September 2022 false true No description of principal activity 1 September 2023 31 August 2024 31 August 2024 11535316 Mr James Smith Mr Amirsaeed Malekshahi Dr Mohammad Ahmadyani iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11535316 2023-08-31 11535316 2024-08-31 11535316 2023-09-01 2024-08-31 11535316 frs-core:CurrentFinancialInstruments 2024-08-31 11535316 frs-core:Non-currentFinancialInstruments 2024-08-31 11535316 frs-bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 11535316 frs-bus:FilletedAccounts 2023-09-01 2024-08-31 11535316 frs-bus:Micro-entities 2023-09-01 2024-08-31 11535316 frs-bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 11535316 frs-bus:Director1 2023-09-01 2024-08-31 11535316 frs-bus:Director2 2023-09-01 2024-08-31 11535316 frs-bus:Director3 2023-09-01 2024-08-31 11535316 2022-08-31 11535316 2023-08-31 11535316 2022-09-01 2023-08-31 11535316 frs-core:CurrentFinancialInstruments 2023-08-31 11535316 frs-core:Non-currentFinancialInstruments 2023-08-31
Registered number: 11535316
Dayonix Pharma Limited
Unaudited Financial Statements
For The Year Ended 31 August 2024
Parousia Limited
Balance Sheet
Registered number: 11535316
2024 2023
£ £
Fixed assets - 171
Current assets 445,492 202,400
Prepayments and accrued income 130,310 -
Creditors: Amounts Falling Due Within One Year (1,238,898 ) (797,371 )
NET CURRENT LIABILITIES (663,096 ) (594,971 )
TOTAL ASSETS LESS CURRENT LIABILITIES (663,096 ) (594,800 )
Creditors: Amounts Falling Due After More Than One Year (21,158 ) (27,195 )
NET LIABILITIES (684,254 ) (621,995 )
CAPITAL AND RESERVES (684,254 ) (621,995 )

Notes

1. General Information
Dayonix Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11535316 . The registered office is 3 Wellesley House, Horton Crescent, Epsom, KT19 8BQ.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2023: 3)
3 3
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Amirsaeed Malekshahi
Director
25/09/2025